Navamedic ASA (FRA:N1A)

Market Cap	45.43M
Revenue (ttm)	46.03M
Net Income (ttm)	-3.23M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	52.17
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	1.760
Previous Close	1.760
Day's Range	1.755 - 1.760
52-Week Range	1.490 - 2.400
Beta	n/a
RSI	45.18
Earnings Date	Apr 29, 2026

About Navamedic ASA

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company’s product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic and propioni...

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 42
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: N1A

Financial Performance

In 2024, Navamedic ASA's revenue was 531.44 million, an increase of 3.80% compared to the previous year's 512.00 million. Losses were -5.49 million, -59.92% less than in 2023.

Financial numbers in NOK